Press Release Sagimet Biosciences Receives FDA “Study May Proceed” Letter and IND Clearance for Phase 3 Trial in Acne in Adolescent and Adult Patients Sagimet Biosciences Inc. · Aug 13
Press Release LENSAR® Reports Second Quarter 2026 Results and Provides Business Update LENSAR, Inc. · Aug 13
Press Release ProQR Announces Second Quarter 2026 Operating and Financial Results ProQR Therapeutics N.V. · Aug 13
Press Release Accro Bioscience to Present Phase Ib Data of AC-101, an Oral Selective RIPK2 Inhibitor, for Moderate-to-Severe UC at UEG Week 2026 in Barcelona Accro Bioscience Inc. · Aug 13
Press Release Insulet Deadline: PODD Investors with Losses in Excess of $100K Have Opportunity to Lead Insulet Corporation Securities Fraud Lawsuit THE ROSEN LAW FIRM, P. A. · Aug 13
Press Release PNR Investors Have Opportunity to Lead Pentair plc Securities Fraud Lawsuit THE ROSEN LAW FIRM, P. A. · Aug 13
Press Release EMBC Deadline: EMBC Investors with Losses in Excess of $100K Have Opportunity to Lead Embecta Corp. Securities Fraud Lawsuit THE ROSEN LAW FIRM, P. A. · Aug 13
Press Release Faraday Future Holds Special Meeting of Stockholders, Securing Approvals on a Number of Proposals to Support Continued EAI Robotics Development and Deliveries in 2026 Business Wire · Aug 13
Press Release Sionna Therapeutics Investigation Notice: Levi & Korsinsky Notifies Investors of Pending Investigation Into Sionna Therapeutics (SION) Levi & Korsinsky, LLP · Aug 13
Press Release NACCE Short Tracks Career Paths at NASCAR National Association for Community College Entrepreneurship · Aug 13